Entropy Technologies LP acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor acquired 33,219 shares of the medical instruments supplier’s stock, valued at approximately $630,000.
A number of other large investors have also added to or reduced their stakes in XRAY. Choreo LLC increased its holdings in shares of DENTSPLY SIRONA by 191.6% during the fourth quarter. Choreo LLC now owns 23,507 shares of the medical instruments supplier’s stock valued at $440,000 after acquiring an additional 15,446 shares in the last quarter. OLD National Bancorp IN increased its stake in DENTSPLY SIRONA by 45.3% during the 4th quarter. OLD National Bancorp IN now owns 18,874 shares of the medical instruments supplier’s stock valued at $358,000 after purchasing an additional 5,884 shares in the last quarter. Pacer Advisors Inc. raised its holdings in DENTSPLY SIRONA by 15,105.1% in the fourth quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after buying an additional 4,473,972 shares during the last quarter. KBC Group NV lifted its stake in shares of DENTSPLY SIRONA by 60.9% in the fourth quarter. KBC Group NV now owns 10,096 shares of the medical instruments supplier’s stock worth $192,000 after buying an additional 3,822 shares in the last quarter. Finally, Blue Trust Inc. lifted its stake in shares of DENTSPLY SIRONA by 10.9% in the fourth quarter. Blue Trust Inc. now owns 7,199 shares of the medical instruments supplier’s stock worth $137,000 after buying an additional 707 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages recently weighed in on XRAY. Needham & Company LLC restated a “buy” rating and issued a $25.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday. UBS Group decreased their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Leerink Partners cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Leerink Partnrs downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Finally, StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. Nine research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus target price of $26.33.
DENTSPLY SIRONA Stock Performance
Shares of NASDAQ XRAY opened at $18.28 on Wednesday. DENTSPLY SIRONA Inc. has a 12-month low of $17.21 and a 12-month high of $34.91. The firm has a market capitalization of $3.63 billion, a price-to-earnings ratio of -8.83, a price-to-earnings-growth ratio of 1.83 and a beta of 0.96. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The firm has a 50 day moving average of $19.06 and a 200 day moving average of $22.07.
DENTSPLY SIRONA Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Stockholders of record on Friday, December 27th were given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s payout ratio is -30.92%.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Read More
- Five stocks we like better than DENTSPLY SIRONA
- Are Penny Stocks a Good Fit for Your Portfolio?
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How to Short a Stock in 5 Easy StepsÂ
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.